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Abnormal uterine bleeding is one of the most common reasons
why women present to hospital gynaecology departments. Even
in developed countries such as Belgium1 a large proportion of
these women are still being offered traditional dilatation and
curettage combined with hysteroscopy under general
anaesthesia, a costly approach that is inconvenient as it involves
an overnight stay in hospital. The dominance of traditional
inpatient dilatation and curettage is currently being challenged
most recently by Cooper and colleagues in the linked study
(doi:10.1136/bmj.h1398) evaluating outpatient diagnosis and
treatment for women with uterine polyps, a common cause of
intrauterine bleeding.2
During dilatation and curettage the operator is unable to see
inside the uterine cavity, and tissue is therefore removed in a
blind manner. The procedure is usually done to rule out
endometrial cancer, and although the diagnostic accuracy for
detecting endometrial cancer is high it is moderate for other
endometrial disease, such as uterine polyps.3 Between 20% and
40% of women with abnormal uterine bleeding have polyps.
Hysteroscopy allows the operator to visualise the entire uterine
cavity, investigate the underlying causes of bleeding, and remove
tissue under direct vision.
Over the past few decades advances in technology have allowed
the development of small calibre endoscopes that can be used
without anaesthesia in an outpatient setting. It is now feasible
to perform outpatient hysteroscopies under local anaesthesia
both for diagnosis and for therapeutic procedures such as the
removal of endometrial polyps.4 5 Treatment can be done at the
moment of diagnosis using the “see and treat” principle. This
approach has many potential benefits for women and for health
systems, including faster diagnosis and treatment of abnormal
bleeding and the avoidance of hospital admission. Therefore
the position of the traditional dilatation and curettage for
diagnosis and treatment of abnormal uterine bleeding has
become questionable.6
Cooper and colleagues’ trial (Outpatient Polyp Treatment, OPT)
is the first large multicentre prospective randomised controlled
trial evaluating the clinical effectiveness of outpatient versus
inpatient polyp removal by hysteroscopy.2 Previous studies
reported an improvement in patients’ symptoms after removal
of polyps by hysteroscopy in the outpatient versus inpatient
setting7 along with good patient tolerability, low pain scores,
and faster recovery after outpatient treatment.8
In the OPT trial women were recruited from 31 outpatient
hysteroscopy clinics in UK National Health Service hospitals:
72% of women allocated to outpatient polypectomywere treated
in “see and treat” clinics. The primary outcome was women’s
own appreciation of their bleeding pattern at six months.
The authors should be applauded for prioritising a patient
reported outcome, and for setting a clear example for future
researchers to follow. Many in this specialty still fail to
understand the importance of patient reported outcomes, which
is regrettable from the viewpoint of the women who participate
in trials, policy makers who use the results to inform decisions,
and health systems that operate inefficiently without data on
outcomes that matter to patients.9 The COMET (Core Outcome
Measures in Effectiveness Trials) Initiative, which supports the
development, reporting, and adoption of a core outcomes set,
may help in this regard.10 11
The potential advantages of outpatient treatment for polyps
include the avoidance of general anaesthesia, immediate
treatment after diagnosis, a half day’s absence from work, and
not having to rely on others for transport after the procedure.
However, the limitations of performing intrauterine surgery in
a conscious patient may well outweigh all these apparent
benefits. The merit of the OPT trial2 lies in clearly determining
the limits of this trade-off. The trial shows that outpatient
treatment is non-inferior to traditional inpatient treatment for
alleviating uterine bleeding.Women treated as outpatients were,
however, on average twice as likely to have only partial or even
failed polyp removals and needed further gynaecological surgery
significantly more often than controls treated as inpatients.
Although women treated as outpatients had higher mean pain
scores than controls, only a fewwomen in both arms found their
treatment unacceptable. More than 90% of women in both arms
would recommend either procedure to friends or relatives. In
qualitative interviews the women treated as outpatients reported
that the pain experienced in the short term was off-set by the
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convenience of a fast relief from their disturbed quality of life
in the longer term. Four women experienced serious adverse
events (2%); all had been treated as inpatients (2%). A full
economic evaluation of the OPT trial was an integral component
from the outset: its findings will be published at a later date.
The body of evidence on the effectiveness, safety, feasibility,
and acceptability of outpatient removal of polyps for treating
abnormal uterine bleeding is now on solid enough ground to
justify establishing outpatient hysteroscopy units so women can
at least have a choice. Technological improvements and a desire
to facilitate rapid recovery and discharge should make
outpatient, ambulatory, or office based interventions more
widespread, in Europe and elsewhere.
The uptake of outpatient hysteroscopy in Belgium is at this
moment seriously hampered by an obsolete reimbursement
system. As women’s healthcare providers it is our responsibility
to discuss the implications of the available evidence with policy
makers of healthcare systems across Europe and worldwide.
For Belgian women, the findings and conclusions of the OPT
trial have come at a critical moment, as discussions have recently
begun to encourage a break with tradition in favour of evidence.
Perhaps change is finally on the way.
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